Pre-Open Stock Movers 01/29: (SANM) (DDD) (WWD) Higher; (GME) (HOG) (RMBS) Lower (more...)

January 29, 2019 9:16 AM

Today's Pre-Open Movers

OncoCyte Corporation (NYSE: OCX) 102.8% HIGHER; announced positive results from its key R&D Validation study demonstrating the accuracy of the Companys DetermaVu liquid biopsy test for lung cancer.

Voyager Therapeutics (NASDAQ: VYGR) 47.5% HIGHER; Neurocrine Biosciences, Inc. (NASDAQ: NBIX) and Voyager announced the formation of a strategic collaboration focused on the development and commercialization of Voyager’s gene therapy programs, VY-AADC for Parkinson’s disease and VY-FXN01 for Friedreich’s ataxia, as well as rights to two programs to be determined.

GameStop Corp. (NYSE: GME) 22.6% LOWER; announced that its Board of Directors has concluded its previously announced efforts to pursue a sale of the company in conjunction with its broader review of strategic and financial alternatives.

Sanmina (NASDAQ: SANM) 21% HIGHER; reported Q1 EPS of $0.83, $0.12 better than the analyst estimate of $0.71. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $1.9 billion. Sanmina sees Q2 2019 EPS of $0.70-$0.80, versus the consensus of $0.66. Sanmina sees Q2 2019 revenue of $1.9-2 billion, versus the consensus of $1.83 billion.

Meritor (NYSE: MTOR) 12.2% HIGHER; reported Q1 EPS of $0.79, $0.18 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $967.48 million. Meritor sees FY2019 EPS of $3.30, versus the consensus of $3.19. Meritor sees FY2019 revenue of $4.3 billion, versus the consensus of $4.29 billion.

3D Systems (NYSE: DDD) 10.9% HIGHER; Piper Jaffray upgraded from Neutral to Overweight with a price target of $17.00.

Woodward (NASDAQ: WWD) 10% HIGHER; reported Q1 EPS of $0.96, $0.21 better than the analyst estimate of $0.75. Revenue for the quarter came in at $653 million versus the consensus estimate of $577.84 million. Woodward sees FY2019 EPS of $4.40-$4.70, versus the consensus of $4.59. Woodward sees FY2019 revenue of $2.65-2.8 billion, versus the consensus of $2.72 billion.

Harley-Davidson (NYSE: HOG) 8.5% LOWER; reported Q4 EPS of $0.17, $0.11 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.05 billion.

Stratasys Inc. (NASDAQ: SSYS) 7.8% HIGHER; Piper Jaffray upgraded from Neutral to Overweight with a price target of $31.00 (from $19.00).

Rambus (NASDAQ: RMBS) 7% LOWER; reported Q4 EPS of $0.09, may not compare to the analyst estimate of $0.26. Revenue for the quarter came in at $68.5 million, may not compare to the consensus estimate of $101.68 million.

Whirlpool (NYSE: WHR) 6.9% LOWER; reported Q4 EPS of $4.75, $0.50 better than the analyst estimate of $4.25. Revenue for the quarter came in at $5.7 billion versus the consensus estimate of $5.76 billion. Whirlpool sees FY2019 EPS of $14.00-$15.00, versus the consensus of $15.92.

AK Steel (NYSE: AKS) 6.3% HIGHER; reported Q4 EPS of $0.16, $0.05 better than the analyst estimate of $0.11. Revenue for the quarter came in at $1.68 billion versus the consensus estimate of $1.7 billion. AK Steel sees FY2019 EPS of $0.51-$0.57, versus the consensus of $0.67. adjusted EBITDA to be in the range of $515 to $535 million.

Xerox Corp. (NYSE: XRX) 6.1% HIGHER; reported Q4 EPS of $1.14, $0.10 better than the analyst estimate of $1.04. Revenue for the quarter came in at $2.53 billion versus the consensus estimate of $2.56 billion. Board approves incremental share repurchase authority of $1.0 billion; company expects at least $300 million of share repurchases in 2019.

Celanese Corp. (NYSE: CE) 5.8% LOWER; reported Q4 EPS of $2.38, $0.02 worse than the analyst estimate of $2.40. Revenue for the quarter came in at $1.69 billion versus the consensus estimate of $1.72 billion. Celanese Corp. sees FY2019 EPS of $10.50, versus the consensus of $11.06.

Rockwell Automation (NYSE: ROK) 5.4% HIGHER; reported Q1 EPS of $2.21, $0.22 better than the analyst estimate of $1.99. Revenue for the quarter came in at $1.64 billion versus the consensus estimate of $1.63 billion. Rockwell Automation sees FY2019 EPS of $8.85-$9.25, versus the consensus of $8.99.

Allergan (NYSE: AGN) 4.9% LOWER; reported Q4 EPS of $4.29, $0.14 better than the analyst estimate of $4.15. Revenue for the quarter came in at $4.08 billion versus the consensus estimate of $4 billion. Allergan sees FY2019 EPS of at least $16.36, versus the consensus of $16.31. Allergan sees FY2019 revenue of $15-15.3 billion, versus the consensus of $15.39 billion. Allergan sees Q1 EPS of $3.40-$3.60, versus the consensus of $3.75. Allergan sees Q1 revenue of $3.40-$3.55 billion, versus the consensus of $3.65 billion.

Square (NYSE: SQ) 4.2% LOWER; Raymond James downgraded from Market Perform to Underperform with a fair value estimate of $56, suggesting 27% downside.

Dynex Capital, Inc. (NYSE: DX) 4% LOWER; announced today that it plans to make a public offering of 7,000,000 shares of its common stock. In connection with the offering, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of its common stock.

Corning (NYSE: GLW) 3.1% HIGHER; reported Q4 EPS of $0.59, $0.02 better than the analyst estimate of $0.57. Revenue for the quarter came in at $3.1 billion versus the consensus estimate of $3.01 billion.

PACCAR (NASDAQ: PCAR) 3% HIGHER; reported Q4 EPS of $1.65, $0.12 better than the analyst estimate of $1.53. Revenue for the quarter came in at $5.93 billion versus the consensus estimate of $5.74 billion.

3M Co. (NYSE: MMM) 3% HIGHER; reported Q4 EPS of $2.31, $0.03 better than the analyst estimate of $2.28. Revenue for the quarter came in at $7.95 billion versus the consensus estimate of $7.87 billion. 3M Co. sees FY2019 EPS of $10.45-$10.90, versus the consensus of $10.75.

Pfizer (NYSE: PFE) 2.9% LOWER; reported Q4 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $13.98 billion versus the consensus estimate of $13.91 billion. Pfizer sees FY2019 EPS of $2.82-$2.92, versus the consensus of $3.04. Pfizer sees FY2019 revenue of $52-54 billion, versus the consensus of $54.36 billion.

Revance Therapeutic (NASDAQ: RVNC) 2.2% HIGHER; Stifel initiates coverage with a Buy rating and a price target of $50.00.

MGM Growth Properties LLC (NYSE: MGP) 1.7% LOWER; commenced an underwritten public offering of 14,500,000 Class A shares. As part of the offering, the Company also intends to grant the underwriters a 30-day overallotment option to purchase up to an additional 2,175,000 shares.

Sensus Healthcare (NASDAQ: SRTS) 1.7% LOWER; Northland Capital Markets downgraded from Market Perform to Underperform with a price target of $5.00 (from $7.00).

Categories

Special Reports

Next Articles